Table 1 Characteristics of the included studies
Study | Country | Research type | Characteristics of participants | Number of participants | Age (years) | Male (%) | TyG index in VDD group | TyG index in no-VDD group | Spearman correlation | Pearson correlation | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean1 | SD1 | n1 | Mean2 | SD2 | n2 | |||||||||
Dhas, [34] | India | case-control | T2DM patients (n=90) Controls (n=90) | 180 | T2DM: 37.97±6.14 Controls: 41.83±5.91 | 56.67% | T2DM 9.05 Controls 8.39 | T2DM 0.56 Controls 0.39 | T2DM 63 Controls 36 | T2DM 9.11 Controls 8.42 | T2DM 0.68 Controls 0.49 | T2DM27 Controls 54 | ρ=-0.272 | |
Aludwan, [35] | Ukraine | cross-sectional | T2DM patients | 109 | 61.46±9.73 | NA | 5.17 | 0.41 | 60 | 5.08 | 0.31 | 49 | r=-0.145 | |
Paredez, [42] | Mexico | cross-sectional | Mexican Adults | 1904 | 48.59 (36.82, 55.80) | 30.57% | r=-0.213 | |||||||
Jia, [36] | China | cross-sectional | T2DM patients | 592 | 58.4±4 | 63.18% | 9.23 | 0.75 | 405 | 9.06 | 0.74 | 187 | r=-0.13 | |
Mustafa, [37] | India | cross-sectional | Indian adolescents | 10167 | adolescents (10-19) | 51.40% | 4.51 | 0.24 | 2505 | 4.45 | 0.24 | 7662 | r=-0.14 | |
Xiang, [38] | China | cross-sectional | T2DM patients | 1034 | 62.0±11.14 | 60.06% | 9.21 | 0.77 | 632 | 8.96 | 0.69 | 402 | r=-0.172 | |
Mahat, [39] | India | case-control | SCH patients (n=75) Controls (n=75) | 150 | SCH: 45.36±11.43 Controls: 44.73±10.21 | 44% | SCH 9.09 | SCH 0.05 | SCH 33 | SCH 8.99 | SCH 0.06 | SCH 42 | SCH ρ=-0.392 | |
Liu, [40] | China | cross-sectional | MAFLD patients | 566 | 52 (42,60) | 59.17% | 9.11 | 0.53 | 366 | 8.66 | 0.48 | 200 | r=-0.434 | |
Zhou, [41] | China | cross-sectional | Euthyroid Adults | 3143 | 47.0±11.9 | 64% | 8.71 | 0.65 | 1849 | 8.63 | 0.60 | 1294 | ||